New Properties of Supramolecular Complexes and Drug Nanoparticles
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (20 May 2024) | Viewed by 42437
Special Issue Editors
Interests: kinetic isotope effect; nanoparticle drugs; supramolecular complexes; laser diffraction spectroscopy; dissolution rate; validation studies
Special Issues, Collections and Topics in MDPI journals
Interests: biokinetics; dispersed systems; analytical chemistry; environmental pollution
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
A Special Issue of the journal Pharmaceutics will be devoted to the presentation of practical results on the study of new properties of drugs, such as supramolecular complexes and nanoparticles. The main task is to offer a description of the mechanism of action of drugs, not only from the point of view of their ligand–receptor interaction but also the physicochemical, dispersion properties of the surface There is considerable interest in research on, not only the nanoparticles of iron oxide, copper, zinc, silver, gold, and so on, but also on transport nanosystems and nanosized supramolecular complexes, which determine the development of a pharmacological effect due to long-range surface forces. This direction provides a fundamental basis for solving many scientific and pharmaceutical problems related to the control of the properties of medium and dispersions. The scope is to expand the boundaries of new possibilities for the use of drugs.
Dr. Elena Uspenskaya
Prof. Dr. Anton V. Syroeshkin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- supramolecular interactions
- molecular docking
- nanodrugs
- dispersion interaction
- derjaguin approximation
- new properties
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.